CEbiotech.com - Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular
searches

All articles

Filters:
Show search box
2019-01-03
Shanghai-Based Hexaell Biotech Secures 50 million RMB ($7.3 million) Series A Financing Fro

Shanghai-Based Hexaell Biotech Secures 50 million RMB ($7.3 million) Series A Financing From Hyfinity Investments

The funding will be used to support the clinical and CFDA registration of the hiHep cell engineering system and further accelerate Hexaell's research and development in liver diseases and cell engineering pipeline ... Read more
Tags Hexaell Biotechnologies